Common Stock, par value $0.0001 per share
- Symbol
- AVR
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 7.01, 9.01 · 8-K
AVRNASDAQEQUITYCurrent
Item 7.01. Regulation FD Disclosure On July 31, 2026, Anteris Technologies Global Corp. (the “Company”) submitted the materials attached as Exhibits 99.1 and 99.2 to the Australian Securities Exchange. Trading on The Nasdaq Global Market is not impacted.…
Press release in this filing
Anteris Technologies Global Corp. (ASX:AVR) – request for trading halt under ASX Listing Rule 17.1 →Anteris Technologies Global Corp. (NASDAQ: AVR, ASX: AVR) is a global healthcare company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Founded in Australia, with a significant presence in Minneapolis, USA, Anteris is a science-driven company with an experienced team of multidisciplinary professionals delivering restorative solutions to structural heart disease patients.
Anteris Technologies Global Corp. · 8-K · Filed 2026-07-31
EX-99.1 2 ef20079178_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Attention: Ms. Monique Burley ASX Listings Compliance Level 40, Central Park 152-158 St Georges Terrace Perth WA 6000 By email: monique.burley@asx.com.au; TradingHaltsPerth@asx.com.au 31 July 2026 Dear Ms. Burley, Anteris Technologies Global Corp. (ASX:AVR) - request for trading halt under ASX Listing Rule 17.1 Pursuant to ASX Listing Rule 17.1, Anteris Technologies Global Corp. (the Company) requests a trading halt in the Company’s securities from the commencement of trading on 31 July 2026. In accordance with ASX Listing Rule 17.1, the Company advises: the trading halt is requested pending its consideration of an inadvertent non-lodgement of cleansing notices in relation to an issue of CHESS Depositary Interests in the Company (CDIs), within five business days of the issue of CDIs, in respect of which the Company intends to seek relief from the Federal Court of Australia (Relief Application); the trading halt is requested to apply until the earlier of such time the Company makes an announcement regarding the outcome of the Relief Application and the commencement of normal trading on ASX on …
Open exhibit ↗EX-99.2 3 ef20079178_ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 Cleansing Notice Update MINNEAPOLIS, United States and BRISBANE, Australia July 31, 2026: Anteris Technologies Global Corp. ( Anteris or the Company ) (NASDAQ: AVR, ASX: AVR) advises that on July 10, 2026, 44,068 CHESS Depositary Interests ( CDIs ) were issued following the exercise of certain November 2025 warrants. Due to an administrative oversight, a cleansing notice under section 708A(6) of the Corporations Act 2001 (Cth) ( Corporations Act ) was not lodged within the prescribed 5 business day period. Anteris intends to lodge a cleansing notice today in relation to the issue of the CDIs notwithstanding it is outside of the prescribed period. Anteris understands the CDIs issued have been sold. Anteris will submit an application to the Federal Court shortly seeking orders for relief under section 1322 of the Corporations Act and seeking an extension of time to lodge the cleansing notice, deeming it to be effective from the date of issue of the relevant CDIs. The Company does not consider the oversight to be price sensitive and the Company did not possess excluded information (as defined in section 708A(7) of the …
Open exhibit ↗